Revitalizing myocarditis treatment through gut microbiota modulation: unveiling a promising therapeutic avenue

Jingyue Wang1,2, Xianfeng Zhang3, Xinyu Yang1,2

  • 1Department of Cardiovascular Medicine, The First Hospital of Jilin University, Changchun, China.

Insights

Emerging research links gut microbiota to myocarditis, an inflammatory heart condition. Targeting gut bacteria may offer new therapeutic strategies for this growing concern.

Area of Science:

  • Cardiology
  • Microbiology
  • Immunology

Background:

  • Gut microbiota significantly influences cardiovascular diseases, including hypertension and atherosclerosis.
  • Recent evidence implicates gut microbiota in the pathogenesis of myocarditis, an inflammatory heart condition causing myocardial damage.
  • Myocarditis is a growing concern, particularly in young adults, and is linked to COVID-19 and vaccinations, yet therapeutic options remain limited.

Purpose of the Study:

  • To review the gut-heart axis, gut microbiota-immune system interactions, and the association between myocarditis and the immune system.
  • To explore the impact of gut microbiota and its metabolites on myocarditis development.
  • To discuss current gut microbiota modulation strategies and future directions for targeting gut microbiota in myocarditis treatment.

Main Methods:

  • Literature review focusing on the gut-heart axis.
  • Analysis of studies linking gut microbiota, immune system, and myocarditis.
  • Examination of therapeutic strategies for modulating gut microbiota.

Main Results:

  • The gut-heart axis is a complex interplay influencing cardiovascular health.
  • Gut microbiota and immune system dysregulation are implicated in myocarditis.
  • Modulating gut microbiota presents a potential, yet underdeveloped, therapeutic avenue for myocarditis.

Conclusions:

  • Targeting the gut microbiota-immune system-myocarditis axis offers a novel approach for myocarditis treatment.
  • Further research is needed to establish gut microbiota as a viable therapeutic target for myocarditis.
  • This review highlights the potential of gut microbiota modulation for managing myocarditis and its complications.

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
9
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
12
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
13
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
12
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
74
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
9